BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20024840)

  • 1. HDAC Inhibitors--CHI's Third Annual Conference.
    Rosato RR
    IDrugs; 2010 Jan; 13(1):13-5. PubMed ID: 20024840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society for Neuroscience - 39th Annual Meeting. Part 2 - Novel therapies for neurodegenerative disorders and other CNS diseases.
    Al-Shamahi A; Kirkham K; Hookes L
    IDrugs; 2009 Dec; 12(12):734-7. PubMed ID: 19943211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.
    Walker K; Padhiar M
    IDrugs; 2010 Jan; 13(1):10-2. PubMed ID: 20024839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society for Neuroscience - 39th Annual Meeting. Part 1 - Novel therapies for the treatment of CNS disorders and pain.
    Al-Shamahi A; Kirkham K; Hookes L
    IDrugs; 2009 Dec; 12(12):731-3. PubMed ID: 19943210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1.
    Walker K; Padhiar M
    IDrugs; 2010 Jan; 13(1):7-9. PubMed ID: 20024838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of histone deacetylase inhibitors for cancer treatment.
    Marchion D; Münster P
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of type-specific anticancer histone deacetylase inhibitors: road to success.
    Noureen N; Rashid H; Kalsoom S
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):625-33. PubMed ID: 20401613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
    Marblestone JG
    IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
    Mitra AP
    IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of histone deacetylase inhibitors Potent active ingredients especially in cancer].
    Heinke R; Sippl W
    Pharm Unserer Zeit; 2010 May; 39(3):183-9. PubMed ID: 20425772
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials in CNS--SMi's eighth annual conference.
    Kirk R
    IDrugs; 2010 Feb; 13(2):66-9. PubMed ID: 20127552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
    Plane G
    IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Hematology--51st annual meeting & exposition. Part 1.
    Shumoogam J; Beecher N
    IDrugs; 2010 Feb; 13(2):57-9. PubMed ID: 20127549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors in cancer therapy.
    Lane AA; Chabner BA
    J Clin Oncol; 2009 Nov; 27(32):5459-68. PubMed ID: 19826124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-BIT Life Sciences' third annual world congress. Anti-neurodegenerative and anti-inflammation biotherapeutics.
    Filep JG
    IDrugs; 2010 Feb; 13(2):73-5. PubMed ID: 20127554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activities of histone deacetylase inhibitors.
    Bolden JE; Peart MJ; Johnstone RW
    Nat Rev Drug Discov; 2006 Sep; 5(9):769-84. PubMed ID: 16955068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Neuroscience--Seventh Biennial FENS Forum.
    Hannan AJ
    IDrugs; 2010 Sep; 13(9):607-9. PubMed ID: 20799140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.
    Kazantsev AG; Thompson LM
    Nat Rev Drug Discov; 2008 Oct; 7(10):854-68. PubMed ID: 18827828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the correct HDAC(s) to treat cognitive disorders.
    Fischer A; Sananbenesi F; Mungenast A; Tsai LH
    Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC inhibitors: a potential new category of anti-tumor agents.
    Pan LN; Lu J; Huang B
    Cell Mol Immunol; 2007 Oct; 4(5):337-43. PubMed ID: 17976313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.